Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research - Lincoln,Nebraska

Verified

Basic Information

Site Overview

Source: Human-provided.

Velocity's Family Medicine research site in Lincoln conducts clinical trials related to general medicine and infectious diseases. Typical studies at this site involve medications for acne, high cholesterol, and other conditions. This site also performs vaccine studies for people of all ages. Acquired by Velocity in 2022, the Lincoln location was founded in 2021 as part of Meridian Clinical Research.Through the partnership with LMEP, the site is easily accessible to thousands of patients, including those established with the practice. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. Our Lincoln team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Medical office

Business Subcategory

Source: Human-provided. Medical office
Source: Trial-derived.
54Total Trials
Source: Trial-derived.
5Recruiting Trials
Source: Trial-derived.
15Active Trials
Source: Trial-derived.
32Completed Trials
Source: Trial-derived.
46Unique Conditions
Source: Trial-derived.
29Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. SARS-CoV-2 (7)Source: Trial-derived. COVID-19 (6)Source: Trial-derived. Influenza (4)Source: Trial-derived. Respiratory Syncytial Virus (4)Source: Trial-derived. Heart Failure (3)Source: Trial-derived. Influenza, Human (3)Source: Trial-derived. Influenza Immunization (3)Source: Trial-derived. Cytomegalovirus (2)

Sponsors

Source: Trial-derived. ModernaTX, Inc. (19)Source: Trial-derived. Merck Sharp & Dohme LLC (4)Source: Trial-derived. Sanofi Pasteur, a Sanofi Company (4)Source: Trial-derived. Seqirus (3)Source: Trial-derived. Currax Pharmaceuticals (2)Source: Trial-derived. Novartis Pharmaceuticals (2)Source: Trial-derived. Novo Nordisk A/S (2)Source: Trial-derived. Abbott Nutrition (1)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Specimen packaging and shipment

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Cardiac monitoring
Source: AI-inferred. Electronic participant diary (eDiary/ePRO)